The goal of the NHLBI Progenitor Cell Biology Consortium (PCBC) is to identify and characterize progenitor cell lineages, to direct the differentiation of stem and progenitor cells to desired cell fates, and to develop new strategies to address the unique challenges presented by the transplantation of these cells.
The 7th Annual PCBC Meeting will be held at Houston Methodist Research Institute, from October 13-14, 2015. A Fellows-Only Session will be held on October 12, 2015.
More details to come.
Tenascin C Promotes Hematoendothelial Development and T Lymphoid Commitment from hPSCs in Chemically Defined Conditions
Gene Uenishi, a graduate student, in Dr. Igor Slukvin’s laboratory under the Thomson Hub Site 02 at the University of Wisconsin – Madison, has recently published an article titled, “Tenascin C Promotes Hematoendothelial Development and T Lymphoid Commitment from Human Pluripotent Stem Cells in Chemically Defined Conditions” in the Stem Cell Reports.
Dr. Joseph Wu and colleagues cordially invite you to attend the upcoming Cardiovascular Tissue Engineering Symposium at Stanford. This event, sponsored by the Stanford Cardiovascular Institute, features a number of PCBC investigators and is free of charge to all PCBC members.
The Director of the NHLBI, Dr. Gary Gibbons, has provided a report about the progress made during Fiscal Year 2014 and the forecast for funding opportunities in FY15.
Please see the attachment to read Dr. Gibbons message to the NHLBI scientific community.
Dr. Jay Zhang at the University of Minnesota recently published an article in Cell Stem Cell:
Stanford University's iPSC Biobank is an NHLBI-funded iPS resource.
Contact the SCVI for specific cardiac disease phenotypes and genetic mutations available. Access the SCVI Biobank, inquire about available iPSC lines and learn how patient's cells can be reprogrammed.
See flyer, below, for additional information.
NHLBI Funding Opportunity Announcements (FOA)
Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator- Directed Therapeutics (R41)
FOA #: RFA-HL-15-026
The PCBC is offering another specialized stem cell course on advance hESCs techniques and cardiovascular differentiation techniques at Stanford University in March 2015. Attached below are course flyers and curriclum your review. Please note that a bioinformatics component will be added to the first week of the course (see course outline attached below).